FIRST CLINICAL STUDY OF RUSSIAN PEGINTERFERON ALFA-2B(ALGERON) IN HEALTHY VOLUNTEERS ArticleFitilev S.B., Tukach A.I., Shkrebniova I.I., Ivanov R.A., Linkova Y.N., Chernovskaya T.V., Vozzhaev A.V., Yakushev V.A.Клиническая фармакология и терапия. Vol. 23. 2014. P.. 99-102
COMPARATIVE PHARMACOKINETIC STUDY OF BIOEQUIVALENCE OF METOPROLOL SUCCINATE PROLONGED DRUG FORMS ArticleFitilev S.B., Yakushev V.A., Titarova Y.Y., Vozzhaev A.V., Shkrebniova I.I.Клиническая фармакология и терапия. Vol. 21. 2012. P.. 82-84
ASSESSING THE IMPLEMENTATION OF THE RECOMMENDATIONS ON SECONDARY CARDIOVASCULAR PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION (A PHARMACO-EPIDEMIOLOGIC STUDY) ArticleOganov R.G., Lepakhin V.K., Fitilev S.B., Levin A.M., Shkrebneva I.I., Titarova Y.Y., Vozzhaev A.V.Cardiovascular Therapy and Prevention. Vol. 8. 2009. P.. 71-75
ОЦЕНКА ГИПОЛИПИДЕМИЧЕСКОЙ ТЕРАПИИ КАК КОМПОНЕНТА ВТОРИЧНОЙ ПРОФИЛАКТИКИ У ПАЦИЕНТОВ, ПЕРЕНЕСШИХ ИНФАРКТ МИОКАРДА (ФАРМАКОЭПИДЕМИОЛОГИЧЕСКОЕ ИССЛЕДОВАНИЕ) ArticleФитилев С.Б., Возжаев А.В., Шкребнева И.И., Титарова Ю.Ю., Сычева Е.А., Журавлев Р.И.Клиническая фармакология и терапия. Vol. 18. 2009. P.. 95-96
QUALITY OF AMBULATORY PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE AND ITS COMPLICATIONS AMONG TYPE 2 DIABETES MELLITUS PATIENTS ArticleOganov R.G., Lepakhin V.K., Fitilev S.B., Levin A.M., Shkrebneva I.I., Titarova Y.Y., Tsiruleva Y.Y.Cardiovascular Therapy and Prevention. Vol. 7. 2008. P.. 9-14
STABLE ANGINA PECTORIS: POPULATION TRENDS, DIAGNOSTICS, SECONDARY PREVENTION, AND ANTIANGINAL THERAPY ArticleOganov R.G., Lepakhin V.K., Fitilev S.B., Levin A.M., Shkrebneva I.I., Titarova Yu.Yu., Doronkina M.K.Cardiovascular Therapy and Prevention. Vol. 5. 2006. P.. 49-54
SECONDARY PREVENTION OF CORONARY HEART DISEASE IN MOSCOW POPULATION PATIENTS WITH MYOCARDIAL INFARCTION ArticleOganov R.G., Lepakhin V.K., Fitilev S.B., Levin A.M., Shkrebneva I.I., Titarova Yu.Yu., Gromakovsaya S.V.Cardiovascular Therapy and Prevention. Vol. 4. 2005. P.. 53-60